Cargando…
Management of patients with hip fracture receiving anticoagulation: What are we doing in Canada?
BACKGROUND: Direct oral anticoagulants (DOACs) are rapidly replacing warfarin for therapeutic anticoagulation; however, many DOACs are irreversible and may complicate bleeding in emergent situations such as hip fracture. In this setting, there is a lack of clear guidelines for the timing of surgery....
Autores principales: | White, Neil J., Reitzel, Sarah L., Doyle-Baker, Douglas, Sabo, Marlis T., Mattiello, Brenna, Samuel, Tina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526126/ https://www.ncbi.nlm.nih.gov/pubmed/34598928 http://dx.doi.org/10.1503/cjs.018520 |
Ejemplares similares
-
Proximal femoral growth disturbance in developmental dysplasia of the hip: what do we know?
por: Weinstein, S. L., et al.
Publicado: (2018) -
Dual mobility in hip arthroplasty: What evidence do we need?
por: Horriat, S., et al.
Publicado: (2018) -
What Do We Know and Not Know about the Professional Integration of International Medical Graduates (IMGs) in Canada?
por: Neiterman, Elena, et al.
Publicado: (2017) -
Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)